| Faculty (Department Wise)+ |
|---|
| ----------------------------- |
| Medicinal Chemistry |
| Process Chemistry |
| Pharmaceutical Analysis |
| Pharmacology & Toxicology |
| Regulatory Toxicology |
| Pharmaceutics |
| Pharmaceutical Management |
| ----------------------------- |
| Young Scientists |
| Guest Faculty |
| ----------------------------- |
| Staff + |
| ----------------------------- |
| Technical Staff |
| Administrative Staff |
Dr. Jitender Madan obtained his M.Pharmacy from Dr. Harisingh Gaur University, Saugar and Ph.D (Pharmaceutical Sciences) from Bundelkhand University, Jhansi. He also worked as Postdoctoral Fellow in Georgia State University, Atlanta, GA, USA in Cancer Nanobiology. Currently, Dr. Madan is associated with Department of Pharmaceutics, NIPER, Hyderabad and continuing academic research in the area of topical drug delivery systems, vaccine delivery, and cancer nanobiology.
Dr. Saurabh Srivastava has pursued his Masters in Pharmaceutical Sciences from “Birla Institute of Technology and Science (BITS), Pilani, Rajasthan and Ph.D. from “Panjab University, Chandigarh”. He carries profound industrial and research experience working with several Pharmaceutical R&Ds, including IPCA labs, Mumbai, Wockhardt research centre, Aurangabad and Dr. Reddy’s Laboratories, Hyderabad for development and commercialization of various NDA and ANDA based products for different regulated markets. His area of research interests are development and optimization of Industrially viable, feasible and scalable “Differentiated formulations” (505(b)2, through utilization of “Micro/Nanostructured” Targeted drug deliveries along with Novel platform technologies, including “Amorphous solid dispersion”, “Fluidized bed processing”, “Particle coating” (Wurster process), “Pellet based controlled drug deliveries” “Compression coating”, Multiple Unit Particulate Systems (MUPS), “Osmotic drug deliveries” and “Lipid based drug carriers” for the purpose of “Bioavailability enhancement”, “Food effect minimization”, “Repurposing/New Indication”, “Synergism for FDCs”, “Dose/Dosing frequency reduction”. His major therapeutic area of research is “Neurodegenerative disorders”, “Dermal diseases”, “GI disorders” and “Chronotherapeutics”. He has 02 “Commercial Products”, 08 “International and National Patents” and several research publications in Journals of International and National repute with 250+ citations to his credit.
His area of interests are "Targeted drug delivery system; Ligand anchored drug targeting; Nanotechnology; Bioavailability improvement; Liposomal drug delivery system; Sustain release dosage form. He is working on targeted drug delivery system for various life-threatening disease, i.e., cancer, visceral leishmaniasis, diabetes, etc."
Full Profile
His area of interests are "Differentiated complex pharmaceutical product development of Ophthalmic, inhalation and Injectables. Formulation development of poorly water-soluble drugs using novel technologies for enhancement of efficacy. Transform of numerous Micro-, Nano-technologies based formulation including Microfluidics, bead milling techniques, Multifunctional Targeted Drug Delivery systems, Polymeric micelles, Liposomes, Nanoparticles, Dendrimers, carbon nanotubes, Quantum dots, Drug-polymer conjugates. Major Areas of Research - Ocular delivery, Onco-Target Products, Topical drug delivery, Micro-/Nanotechnologies for Bioactives Delivery and Targeting."
Full Profile